article thumbnail

Filings buzz in pharmaceuticals: 65% increase in cloud computing mentions in Q1 of 2022

Pharmaceutical Technology

In total, the frequency of sentences related to cloud computing between April 2021 and March 2022 was 133% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. Other top employers with high cloud mentions included GSK, Roche and Pfizer.

article thumbnail

Optimize Pharmacy Outcomes and Simplify Operations with the Cloud

Omnicell

Since Omnicell manages, protects, upgrades, and backs up OmniCenter data, the pharmacy is less dependent on in-house IT resources and has access to what they need to run their business effectively. In addition to increasing the available physical space, this will ease the burden of managing software and hardware upgrades. Subscribe today.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Optimize Pharmacy Outcomes and Simplify Operations with the Cloud

Omnicell

Since Omnicell manages, protects, upgrades, and backs up OmniCenter data, the pharmacy is less dependent on in-house IT resources and has access to what they need to run their business effectively. In addition to increasing the available physical space, this will ease the burden of managing software and hardware upgrades. Subscribe today.

article thumbnail

Filings buzz in pharmaceuticals: 22% decrease in robotics mentions in Q1 of 2022

Pharmaceutical Technology

In total, the frequency of sentences related to robotics between April 2021 and March 2022 was as frequent as in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. Secondly, we calculated the percentage of total analysed sentences that referred to robotics.

article thumbnail

Manual IV Compounding – a Potential Recipe for Disaster?

Omnicell

In 2016, we implemented our first non-hazardous compounding robot to support automated production of ready-to-administer (RTA) syringes. Insourcing with Omnicell’s IV robot has also given us greater control over inventory, quality, and drug spend.

article thumbnail

After a Lull in Action, Expect 340B to Be Under the Microscope in the Next Congress

Omnicell

Keep an Eye on GOP-Led Energy and Commerce Committee The last time Republicans controlled the committee from 2016 to 2018, it held numerous hearings on the program and considered—but did not pass—over a dozen GOP-sponsored bills that would have changed 340B to the benefit of drug manufacturers.

article thumbnail

Why 340B Covered Entities Need Swift Action on Contract Pharmacies

Omnicell

HRSA was mandated by Congress to finalize the ADR rule over 10 years ago but did not publish a proposed regulation for notice and comment until August 2016 , during the last year of the Obama administration. The Trump administration first froze the proposed regulation in January 2017 and then withdrew it in August 2017.